Our market reports now include the latest updates on global tariffs, trade impacts, and evolving supply chain dynamics.
How has the enzyme-linked immunosorbent assay (elisa) analyzers market size changed in recent years, and what is the outlook ahead?
The enzyme-linked immunosorbent assay (ELISA) analyzers market size has grown strongly in recent years. It will grow from $0.71 billion in 2024 to $0.76 billion in 2025 at a compound annual growth rate (CAGR) of 6.4%. The growth in the historic period can be attributed to the increasing need for high-throughput screening in drug discovery, the rising geriatric population with higher disease susceptibility, the increasing adoption of point-of-care diagnostics, the rising healthcare expenditure globally, and the growing demand for reliable and reproducible diagnostic tools.
The enzyme-linked immunosorbent assay (ELISA) analyzers market size is expected to see strong growth in the next few years. It will grow to $0.96 billion in 2029 at a compound annual growth rate (CAGR) of 6.2%. The growth in the forecast period can be attributed to increasing demand for personalized medicine, rising focus on precision diagnostics, growing investment in healthcare research and development, increasing collaborations between research institutions and diagnostic companies, and a rise in the adoption of miniaturized and portable diagnostic devices. Major trends in the forecast period include advancement in multiplexing capabilities, advanced integration with artificial intelligence for data analysis, innovation in portable and handheld ELISA analyzers, integration of ELISA with microfluidics for faster results, and advancement in automation and robotics for high-throughput screening.
Download Your Free Sample PDF:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24216&type=smp
What are the top economic and technological drivers pushing enzyme-linked immunosorbent assay (elisa) analyzers market growth?
The rising prevalence of infectious diseases is expected to propel the growth of the enzyme-linked immunosorbent assay (ELISA) analyzers market going forward. Infectious diseases are illnesses triggered by harmful microorganisms such as bacteria, viruses, fungi, or parasites, which can be transmitted directly or indirectly between individuals. The rising prevalence of infectious diseases can be mainly attributed to increased human interaction with the environment and global interconnectedness. ELISA analyzers support the detection of infectious diseases by identifying specific antibodies or antigens in blood samples, enabling rapid and accurate diagnosis, which helps monitor and manage disease outbreaks. For instance, in March 2025, according to the World Health Organization, a Switzerland-based intergovernmental organization, in 2023, an estimated 10.8 million people fell ill with Tuberculosis (TB) (a common bacterial infection) worldwide, including 6.0 million men, 3.6 million women, and 1.3 million children. Therefore, the rising prevalence of infectious diseases drives the growth of the enzyme-linked immunosorbent assay (ELISA) analyzers market.
How is the enzyme-linked immunosorbent assay (elisa) analyzers market segmented by product, application, and end-user?
The enzyme-linked immunosorbent assay (ELISA) analyzers market covered in this report is segmented –
1) By Product Type: Bench-Top Enzyme-Linked Immunosorbent Assay (ELISA) Analyzers, Portable Enzyme-Linked Immunosorbent Assay (ELISA) Analyzers, Automated Enzyme-Linked Immunosorbent Assay (ELISA) Workstations, Microplate Readers
2) By Technology: Colorimetric Enzyme-Linked Immunosorbent Assay (ELISA) Analyzers, Fluorescence Enzyme-Linked Immunosorbent Assay (ELISA) Analyzers, Chemiluminescence Enzyme-Linked Immunosorbent Assay (ELISA) Analyzers, Electrochemical Enzyme-Linked Immunosorbent Assay (ELISA) Analyzers
3) By Application: Vaccines Development, Immunology, Diagnosis, Toxicology, Drug Monitoring And Pharmaceutical Industry, Other Applications
4) By End-User: Diagnostic Laboratories, Research Institutions, Food And Beverage Industry
Subsegments:
1) By Bench-Top ELISA Analyzers: Manual Bench-Top Enzyme-Linked Immunosorbent Assay (ELISA) Analyzers, Semi-Automated Bench-Top Enzyme-Linked Immunosorbent Assay (ELISA) Analyzers, Fully Automated Bench-Top Enzyme-Linked Immunosorbent Assay (ELISA) Analyzers
2) By Portable ELISA Analyzers: Handheld Enzyme-Linked Immunosorbent Assay (ELISA) Analyzers, Compact Desktop Enzyme-Linked Immunosorbent Assay (ELISA) Analyzers, Battery-Powered Enzyme-Linked Immunosorbent Assay (ELISA) Analyzers
3) By Automated Enzyme-Linked Immunosorbent Assay (ELISA) Workstations: Single-Channel Automated Enzyme-Linked Immunosorbent Assay (ELISA) Workstations, Multi-Channel Automated Enzyme-Linked Immunosorbent Assay (ELISA) Workstations, High-Throughput Automated Enzyme-Linked Immunosorbent Assay (ELISA) Workstations
4) By Microplate Readers: Colorimetric Microplate Readers, Fluorescence Microplate Readers, Luminescence Microplate Readers, Multimode Microplate Readers
View The Full Market Report:
What evolving trends are creating new opportunities in the enzyme-linked immunosorbent assay (elisa) analyzers market?
Major companies operating in the enzyme-linked immunosorbent assay (ELISA) analyzers market are focusing on developing advanced products such as multi-mode microplate readers to enable high-throughput screening for various diagnostic and research applications. Multi-mode microplate readers are versatile instruments that integrate multiple detection technologies into one platform. They enable diverse assays such as ELISA and nucleic acid quantification, enhancing lab efficiency, accuracy, and throughput. For instance, in April 2022, Molecular Devices, LLC, a US-based high-performance life science solutions provider, launched SpectraMax, a compact and budget-friendly instrument designed for academia and biotech laboratories. This user-upgradeable reader supports up to three detection modes, such as UV-visible absorbance, fluorescence, and luminescence, enabling a wide range of applications such as ELISA, DNA/protein quantitation, reporter gene expression, and cell viability assays. It accommodates various plate formats (6- to 384-well), features an extended fluorescence wavelength range (250 to 850 nm) using a xenon flash lamp, and offers easy use with plug-and-play filter cubes. The device is integrated with SoftMax Pro Software for efficient protocol control and data analysis, making it a versatile and space-saving solution for research labs.
Which leading companies are dominating the enzyme-linked immunosorbent assay (elisa) analyzers market landscape?
Major companies operating in the enzyme-linked immunosorbent assay (ELISA) analyzers market are Thermo Fisher Scientific Inc., Abbott Laboratories, Agilent Technologies Inc., Shenzhen Mindray Bio-Medical Electronics Co. Ltd., BioMerieux, Beckman Coulter Inc., Bio-Rad Laboratories Inc., Tecan Group Ltd., EUROIMMUN Medizinische Labordiagnostika AG, Molecular Devices LLC, Quanterix, Berthold Technologies GmbH and Co. KG, Trinity Biotech Public Limited Company, Erba Mannheim GmbH, Dynex Technologies Inc., BMG Labtech GmbH, Awareness Technology Inc., Medicon Hellas S.A., Adaltis S.r.l., Gold Standard Diagnostics Corp.
Which geographic areas are expected to offer the highest growth opportunities in theenzyme-linked immunosorbent assay (elisa) analyzers market?
North America was the largest region in the enzyme-linked immunosorbent assay (ELISA) analyzers market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the enzyme-linked immunosorbent assay (ELISA) analyzers market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
How Can Companies Use The Enzyme-Linked Immunosorbent Assay (ELISA) Analyzers Market Report to Drive Business Results?
This report provides actionable insights tailored for business use—not academic analysis. Companies can leverage the data to:
• Time market entry or expansion using growth forecasts and CAGR trends.
• Develop competitive products by tracking key technology shifts and user preferences.
• Tailor regional strategies with in-depth geographic data and local market dynamics.
• Benchmark and plan partnerships using competitive landscape insights.
Purchase The Report And Get A Swift Delivery:
https://www.thebusinessresearchcompany.com/customise?id=24216&type=smp
Need Customized Data On Enzyme-Linked Immunosorbent Assay (ELISA) Analyzers Market?
For companies needing more tailored intelligence, The Business Research Company offers customized consulting and data services. Whether you’re entering new regions, launching innovative products, or assessing M&A opportunities, our experts can develop actionable insights specific to your business objectives.
Request Customized Data:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24216&type=smp
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
https://thebusinessresearchcompany.com/
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
